RecruitingNot Applicable

Clinical Explorative Optical Breast Investigations

Sweden90 participantsStarted 2020-12-01

Plain-language summary

This study evaluates diffuse reflectance spectroscopy and photoacoustic imaging for differentiating healthy, benign, and malignant breast tissue by identifying their optical profiles.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * solitary malignant or benign biopsy verified tumour \> 1 cm * understands written and oral Swedish Exclusion Criteria: * previous breast surgery * has received neoadjuvant chemotherapy * skin burns in on the chest

What they're measuring

Number of study subjects with correctly classified breast tissue type with PAI/DRS

Timeframe: 30 days

Trial details

NCT IDNCT06857669

SponsorRegion Skane

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12-31

Contact for this trial

Sophia Zackrisson, MD, PhD

+46 40 33 87 97 sophia.zackrisson@med.lu.se

View on ClinicalTrials.gov More Benign Breast Tumors trials